| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.4M | — | +0.1% |
| Cost of Revenue | $15.5M | — | +7.8% |
| Gross Profit | $6.9M | — | -13.7% |
| R&D Expense | $936K | — | +2.6% |
| SG&A Expense | $8.4M | — | +10.2% |
| Operating Income | -$4.9M | — | -68.6% |
| Pre-tax Income | -$6.9M | — | -103.7% |
| Income Tax | -$385K | — | -156.7% |
| Net Income | -$6.5M | — | -101.2% |
| EPS (Basic) | -$2.25 | — | +73.4% |
| EPS (Diluted) | -$2.25 | — | +73.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.9M | -26.5% | — |
| Accounts Receivable | $13.8M | -10.1% | — |
| Inventory | $36.6M | -4.0% | — |
| Current Assets | $65.5M | -5.7% | — |
| Total Assets | $90.7M | -7.0% | — |
| Current Liabilities | $40.2M | -6.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | -7.9% |
| Capital Expenditures | $42K | — | -66.9% |
| Investing Cash Flow | -$42K | — | +66.9% |
| Financing Cash Flow | $3.1M | — | -33.3% |
| Free Cash Flow | -$5.1M | — | -5.9% |
| Long-term Debt | $34.1M | -0.0% | — |
| Total Liabilities | $92.7M | -3.7% | — |
| Stockholders' Equity | -$2.0M | -260.2% | +87.3% |